Showing 3 posts of 3 posts found.


FDA approves multiple myeloma therapy Xpovio despite safety concerns

July 4, 2019
Sales and Marketing FDA, Karyopharm, Xpovio, multiple myeloma, pharma

The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio (selinexor) from Karyopharm Therapeutics, in combination …

Biogen announces acquisition along with financials, but it’s tiny

January 26, 2018
Medical Communications, Sales and Marketing Biogen, Karyopharm, biotech, drugs, pharma, pharmaceutical

Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …


Bad start to month for Karyopharm gets worse with clinical hold

March 13, 2017
Sales and Marketing Karyopharm

Coming just over a week after Karyopharm Therapeutics had announced that its lead drug had failed in a Phase 2 …

Latest content